Acinetobacter radioresistens: A Silent Source of Resistance

Acinetobacter radioresistens is a mostly harmless bacterium that lives on human skin, yet it harbors a gene responsible for one of the most alarming forms of antibiotic resistance spreading through hospitals worldwide. Research has identified it as the original source of the blaOXA-23 gene, which encodes an enzyme capable of destroying carbapenems, the powerful antibiotics often reserved as a last resort against multidrug-resistant infections.¹ The organism itself rarely causes disease, and when it carries this gene it often remains fully susceptible to the very drugs the gene can defeat. That paradox is what makes it dangerous in a way nobody expected for decades.

A Quiet Resident of Human Skin

A. radioresistens belongs to a large genus of bacteria found in soil, water, and on animals. Many Acinetobacter species colonize people without causing problems, and A. radioresistens is one of the more common ones living harmlessly on healthy skin. A survey of 192 healthy volunteers found that over 40% carried Acinetobacter at one or more body sites, with the forearm, forehead, and toe web being the most frequently colonized areas. A. radioresistens accounted for roughly 12.5% of the Acinetobacter isolates recovered from those volunteers.² It shares this skin-dwelling habit with its far more notorious relative, A. baumannii, which is one of the most feared hospital pathogens on the planet. The two species coexist on human skin and in hospital environments, and that proximity turns out to be the crux of the resistance problem.

How a Harmless Bug Became the Origin of Carbapenem Resistance

Carbapenems are broad-spectrum antibiotics that doctors reach for when other drugs fail. Resistance to them in A. baumannii has become a global crisis, and the enzyme most commonly responsible is OXA-23, a class D carbapenemase. For years, the evolutionary origin of the gene encoding OXA-23 was unclear. Then researchers screened a collection of 50 Acinetobacter strains spanning several species and discovered that five A. radioresistens isolates carried blaOXA-23-like genes encoded on their chromosomes. The strains were all susceptible to carbapenems despite carrying the gene.³ That finding established A. radioresistens as the progenitor of the blaOXA-23-like genes now emerging as the primary drivers of carbapenem resistance in A. baumannii worldwide.¹

The mechanism is gene transfer. Bacteria can swap genetic material through mobile elements like plasmids and insertion sequences. Researchers found a similar plasmid backbone in several blaOXA-23-positive A. baumannii and A. radioresistens isolates, providing strong evidence that the gene had jumped between the two species via these shared vectors.³ Because both species live on human skin and in hospital settings, the opportunities for this transfer are constant. Every time an A. baumannii strain picks up the gene and survives antibiotic treatment, the resistance spreads further, but the original reservoir in A. radioresistens persists quietly in the background.

Why It Stays Susceptible to Its Own Weapon

One of the stranger aspects of this story is that A. radioresistens typically does not use the resistance gene it carries. Isolates harboring blaOXA-23-like genes have been found fully susceptible to penicillins, carbapenems, cephalosporins, and aminoglycosides.⁴ The gene sits on the chromosome in what appears to be a quiescent state, expressed at levels too low to confer actual resistance. In A. radioresistens, the gene is essentially baggage, a leftover from evolutionary history rather than an active defense.

But once that gene lands in A. baumannii, the picture changes. Insertion sequences, short stretches of DNA that can hop around a genome, can park themselves upstream of the blaOXA-23 gene and act as strong promoters, cranking up its expression. When the gene is expressed at high levels, the resulting enzyme chews through carbapenems efficiently. So the same gene that sits dormant in its species of origin becomes a potent resistance mechanism in its new host. This is part of what makes surveillance so difficult: you cannot identify the threat just by looking at the antibiotic susceptibility profile of the organism carrying it.

A Diagnostic Blind Spot

Compounding the surveillance challenge, A. radioresistens is frequently misidentified in clinical labs. A comparative study of diagnostic methods found that the widely used VITEK 2 automated system misidentified four out of the tested strains.⁵ Conventional biochemical methods also struggle with the species, leading to cases where infections are attributed to a different Acinetobacter or missed entirely.⁶

There is also a cultural problem in microbiology labs. Because A. radioresistens is considered clinically unimportant most of the time, labs may not bother to identify it to the species level at all. If it grows on a culture plate from a skin swab, a technician might report it as “Acinetobacter species” and move on. That means the organism’s true prevalence in both clinical and commensal settings is almost certainly underestimated.⁵ When researchers do use molecular techniques like 16S rRNA gene sequencing or MALDI-TOF mass spectrometry, identification accuracy improves dramatically. But those tools are not universally available, and many community hospitals still rely on the older biochemical systems.

This identification gap has practical consequences. If labs cannot reliably detect A. radioresistens, epidemiologists cannot track how often it co-occurs with A. baumannii in hospital environments, which patients carry it, or how frequently gene transfer events happen. The silent reservoir stays silent partly because we are not looking hard enough.

When It Does Cause Disease

Though primarily a commensal organism, A. radioresistens can occasionally cause serious infections, particularly in people with weakened immune systems. Published case reports describe bacteremia, pneumonia, and septic shock in patients with underlying conditions like cancer, chronic lung disease, and other immunocompromising states.⁷ Community-acquired infections in otherwise healthy people have also been documented, though they are rare.⁸

These cases are concerning not because A. radioresistens infections are common, but because they highlight how easily the organism can be overlooked. When it does infect someone, the misidentification problem described above means it may be labeled as a different Acinetobacter species. If clinicians treat it based on that wrong label, they might choose the wrong antibiotic or underestimate the risk of resistance gene transfer to other organisms in the patient’s body. As more cases are recognized through improved diagnostics, clinicians are beginning to view the species with greater suspicion than they did a decade ago.

Extraordinary Radiation Resistance

The species name “radioresistens” is not decorative. A. radioresistens tolerates gamma radiation at levels four to eight times higher than other Acinetobacter species.⁸ This is a remarkable degree of hardiness for a non-spore-forming bacterium. The ability to survive radiation damage implies robust DNA repair machinery, since ionizing radiation kills most bacteria by shattering their DNA. Organisms that can piece their genomes back together quickly have a survival advantage in harsh environments, and A. radioresistens clearly has that advantage.

This radiation tolerance connects to a broader pattern of environmental resilience. The organism can persist on dry surfaces for extended periods and withstand conditions that would kill many other bacteria. That persistence is relevant to hospitals, where thorough surface decontamination is supposed to prevent transmission of dangerous organisms. If A. radioresistens can survive on surfaces longer than expected, it has more opportunities to share its resistance genes with susceptible A. baumannii strains that happen to land nearby.

From Spacecraft to Antarctica

The survival capabilities of A. radioresistens have drawn attention from an unexpected quarter: space agencies. Despite rigorous cleaning protocols, spacecraft assembly facilities maintain a persistent core microbiome, and Acinetobacter species are among the dominant members of that community.⁹ One particular strain, 50v1, was isolated directly from the surface of NASA’s Mars Odyssey spacecraft. When compared to a reference strain isolated from cotton and soil on Earth, the spacecraft strain showed higher resistance to antimicrobial surfaces, suggesting that the selective pressures inside cleanroom environments may have inadvertently favored hardier variants.¹⁰

Meanwhile, at the other end of the planet, researchers have characterized an A. radioresistens strain isolated in Antarctica that harbors multiple antibiotic-resistance genes.⁴ Finding resistance genes in a bacterium from one of the most remote and least human-impacted environments on Earth underscores a troubling reality: antibiotic-resistance genes are not strictly a product of clinical antibiotic use. They have ancient evolutionary roots and can be found in organisms far removed from hospitals. The Antarctic finding also demonstrates that the species’ resistance gene repertoire is more diverse than the blaOXA-23 story alone suggests, encompassing genes involved in resistance to heavy metals and other stressors as well.

Biofilm and Hospital Persistence

One of the biggest challenges in controlling Acinetobacter species in healthcare settings is their ability to form biofilms, thin layers of bacteria encased in a protective matrix that clings to surfaces like bedrails, ventilator tubing, and sinks. Research on A. baumannii has shown that while standard hospital disinfectants like bleach, ethanol, and chlorhexidine can eliminate the vast majority of free-floating bacteria, biofilms are another matter entirely. Disinfectants that wiped out over 99.9% of planktonic cells were far less effective against the same bacteria growing in a biofilm.¹¹ Though that particular study focused on A. baumannii, the broader Acinetobacter genus shares biofilm-forming tendencies, and the implications for A. radioresistens are similar: if the organism is clinging to a hospital surface in a biofilm, routine cleaning may not eliminate it.

This matters because gene transfer between bacteria happens efficiently inside biofilms. The close physical proximity and shared extracellular environment create ideal conditions for plasmids and other mobile genetic elements to jump from one cell to another. A mixed biofilm containing both A. radioresistens and A. baumannii is, in effect, a natural laboratory for the generation of carbapenem-resistant strains.

A Talent for Breaking Down Pollutants

Not everything about A. radioresistens is alarming. The species has drawn interest for its ability to degrade aromatic compounds, a class of environmental pollutants that includes phenol and benzoate. One well-studied strain, S13, can use phenol or benzoate as its sole carbon and energy source, breaking them down through dedicated enzymatic pathways encoded on its chromosome.¹² The genes for these pathways are organized into at least two separate clusters, one for benzoate and one for phenol, each encoding the enzymes needed for complete degradation.

This metabolic versatility has potential applications in bioremediation, the use of microorganisms to clean up contaminated environments. Industrial sites polluted with phenol-containing waste, for instance, could benefit from bacteria that naturally consume these compounds. And because A. radioresistens can also tolerate radiation, desiccation, and a variety of chemical stressors, it might be suited to cleanup efforts in environments too harsh for other microbes. Researchers studying the strains found in spacecraft cleanrooms noted a similar metabolic flexibility, with some strains able to metabolize the very cleaning reagents designed to eliminate them.⁹ Whether this versatility can be harnessed without introducing resistance genes into new environments is an open question, and one that makes any applied use of the species a careful balancing act.

Genomic Diversity Across Environments

Whole-genome studies have begun to reveal how much A. radioresistens varies from one environment to another. Comparative genomic analysis of strains isolated from very different niches, such as murine intestinal crypts versus human skin versus Antarctic soil, has shown marked differences in antibiotic-resistance gene profiles and heavy-metal resistance genes.¹³ This diversity means that generalizing about the species based on a handful of clinical or environmental isolates is risky. A strain from a hospital patient’s skin might carry a very different set of mobile genetic elements than one found in polar soil, and the resistance risks they pose could differ accordingly.

Genomic work has also confirmed that the blaOXA-23 gene in A. radioresistens sits in a chromosomal location, not on a mobile plasmid, in the species’ “native” state. It is when insertion sequences mobilize the gene onto a plasmid that it becomes transferable to other species. Tracking which A. radioresistens populations carry the insertion sequences capable of liberating the gene is a surveillance priority, but one that requires the kind of genomic sequencing capacity not yet routine in most clinical microbiology labs. Until that capacity becomes standard, the species will continue to operate in what researchers have aptly called its role as a “silent source,” contributing to the spread of resistance in ways that are invisible to conventional surveillance.

1
Antimicrobial Agents and Chemotherapy. Acinetobacter radioresistens as a Silent Source of Carbapenem Resistance for Acinetobacter spp
2
PubMed. Distribution of Acinetobacter species on skin of healthy humans
3
PubMed Central. Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp.
4
Frontiers in Cellular and Infection Microbiology. Genetic Features of Antarctic Acinetobacter radioresistens Strain A154 Harboring Multiple Antibiotic-Resistance Genes
5
PubMed Central. Comparative Study of Different Diagnostic Routine Methods for the Identification of Acinetobacter radioresistens
6
IDCases. Acinetobacter radioresistens infection with bacteremia and pneumonia
7
PubMed Central. Emerging Threat of Acinetobacter radioresistens Infection in Immunocompromised Patients
8
PubMed Central. Community-Acquired Acinetobacter radioresistens Bacteremia in an Immunocompetent Host
9
PubMed Central. Metabolism and Biodegradation of Spacecraft Cleaning Reagents by Strains of Spacecraft-Associated Acinetobacter
10
BIOspektrum. Survival of the NASA Mars Odyssey isolate Acinetobacter radioresistens 50v1 on different spaceflight relevant antimicrobial surfaces
11
PubMed Central. Evaluating the Effectiveness of Hospital Antiseptics on Multidrug-Resistant Acinetobacter baumannii: Understanding the Relationship between Microbicide and Antibiotic Resistance
12
PubMed. Degradation of aromatic compounds by Acinetobacter radioresistens S13: growth characteristics on single substrates and mixtures
13
BMC Genomics. Comparative genomic analysis of Acinetobacter strains isolated from murine colonic crypts